Delivery Order SPE2DB22D3501-SPE2DB25FXL00
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Bromfenac Sodium 0.09% eye drops (1.7 mL) with a ceiling value of $7,904.95. This firm fixed-price delivery order is non-competitive and represents a single pharmaceutical product delivery to support federal medical supply needs. The contract is set to reach ultimate completion by August 13, 2025, with performance conducted from the contractor's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,554.70 to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops (1.7 mL units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply delivery under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7mL units, with a contract ceiling value of $9,699.75. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of May 21, 2025. The delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,139.92 to AmerisourceBergen Drug Corp for the supply of Bromfenac Sodium 0.09% eye drops (1.7mL units). This firm fixed-price delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency awarded a $3,013.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561947313 Bromfenac Sodium 0.09% eye drops in 1.7ml bottles. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 25, 2023 through August 28, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain...
- This is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Bromfenac Sodium 0.09% eye drops. The contract is valued at $3,011.19 and has a firm fixed price pricing type. The ultimate completion date for this order is February 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7 ml containers. The contract has a ceiling value of $1,714.13 and a performance period ending on July 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,383.81 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a $1,417.94 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Bromfenac Sodium 0.09% eye drops, a prescription pharmaceutical product. There is no set-aside designation for this award. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXL00Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7ml units, with a ceiling value of $1,873.23. This non-competitive, firm fixed price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, supplying a broad portfolio of medications and medical supplies across multiple therapeutic domains. The company's inclusion as a prime vendor reflects its capability to meet federal procurement requirements and support Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/19/25 |